InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| LPS-EK (LPS from E. coli K12) | Metabolic Phenotypes of Response to Vaccination in Humans. | 2017 | Cell. | Li S. et al. | DOI: 10.1016/j.cell.2017.04.026 |
| Imiquimod VacciGrade™ (R837) | K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Target... | 2016 | Immunity. | Groß C.J. et al. | DOI: 10.1016/j.immuni.2016.08.010 |
| Pam3CSK4 | Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen... | 2017 | Sci Rep. | Madan-Lala R. et al. | DOI: 10.1038/s41598-017-02804-y |
| 293/TLR4-MD2-CD14 | Role of S100A9 in the development of neutrophilic inflammation in asthmatics ... | 2017 | Clin Immunol. | Lee TH. et al. | DOI: 10.1016/j.clim.2017.08.013 |
| pCpGfree-promoter | A novel upstream enhancer of FOXP3, sensitive to methylation-induced silencin... | 2014 | Eur J Immunol. | Kennedy A. et al. | DOI: 10.1002/eji.201444453 |
| Alhydrogel® adjuvant 2% | Optimization of physiological properties of hydroxyapatite as a vaccine adjuv... | 2016 | Vaccine. | Hayashi M. et al. | DOI: 10.1016/j.vaccine.2015.11.059 |
| CL075 (3M002) | TLR8 Couples SOCS-1 and Restrains TLR7-Mediated Antiviral Immunity, Exacerbat... | 2016 | J Immunol. | Paul A.M. et al. | DOI: 10.4049/jimmunol.1600902 |
| MSU Crystals | Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRI... | 2016 | J Immunol. | Primiano M.J. et al. | DOI: 10.4049/jimmunol.1600035 |
| FLA-ST (Standard or Ultrapure) | NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory di... | 2016 | Nat Immunol. | Mortimer L. et al. | DOI: 10.1038/ni.3538 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method revea... | 2017 | PLoS One. | Teodorowicz M. et al. | DOI: 10.1371/journal.pone.0173778 |
| PGN-SA peptidoglycan preparation | Antimicrobial peptide gene cecropin-2 and defensin respond to peptidoglycan i... | 2017 | Comp Biochem Physiol B Biochem Mol Biol. | Liu S.H. et al. | DOI: 10.1016/j.cbpb.2017.01.004 |
| 2'3'-cGAMP | Activation of STING requires palmitoylation at the Golgi. | 2016 | Nat Commun. | Mukai K. et al. | DOI: 10.1038/ncomms11932 |
| UNC93B1 | Activation of cell membrane-localized Toll-like receptor 3 by siRNA. | 2017 | Immunol Lett. | Pirher N. et al. | DOI: 10.1016/j.imlet.2017.03.019 |
| Loxoribine | TLR7 promotes tumor progression, chemotherapy resistance and poor clinical ou... | 2014 | Cancer Res. | Chatterjee S. et al. | DOI: 10.1158/0008-5472.CAN-13-2698 |
| IFN-α/β Reporter HEK 293 Cells | Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs. | 2014 | Nat Chem Biol. | Li L. et al. | DOI: 10.1038/nchembio.1661 |
| THP1-Dual™ KO-TREX1 Cells | cGAS is activated by DNA in a length-dependent manner. | 2017 | EMBO Rep. | Luecke S. et al. | DOI: 10.15252/embr.201744017 |
| TDB VacciGrade™ | Protective efficacy of a lipid antigen vaccine in a guinea pig model of tuber... | 2017 | Vaccine. | Larrouy-Maumus G. et al. | DOI: 10.1016/j.vaccine.2017.01.079 |
| G418 (Geneticin) | Anti-apoptotic Mcl-1 is essential for the development and sustained growth of... | 2012 | Genes Dev. | Glaser S.P. et al. | DOI: 10.1101/gad.182980.111 |
| Anti-HER2 (Trastuzumab biosimilar - IgG4 (S228P) isotype) | Surrogate CD16-expressing effector cell lines for determining the bioactivity... | 2017 | J Pharm Biomed Anal. | Gurjar S.A. et al. | DOI: 10.1016/j.jpba.2017.06.004 |
| Pam3CSK4 VacciGrade™ | Mumps Virus SH protein inhibits NF-κB activation by interacting with TNFR1, I... | 2017 | J Virol. | Franz S. et al. | DOI: 10.1128/JVI.01037-17 |